NCT07316569

Brief Summary

The HEAL Diabetes Program is a multicomponent intensive plant-forward healthy eating program designed to reverse diabetes. Several recent studies, most notably the Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) in England and Scotland, have demonstrated that intensive programs for weight loss and weight loss maintenance can lead to long-term remission of diabetes for as many as half of patients with early Type 2 (adult-onset) diabetes. Furthermore, the U.S. Preventive Services Task Force has recommended that all patients with obesity and at highest risk for diabetes be referred to such intensive multicomponent behavioral weight loss interventions, but no such programs are available for people living in the low-income and underserved areas of Memphis. This effort will pilot an innovative, culturally tailored, and intensive healthy eating program designed to reverse diabetes based in the UTHSC Neighborhood Health Hub located in low-income neighborhoods to demonstrate that this approach will work in Memphis to improve and extend people's lives. The HEAL Diabetes Pilot Program will: a) engage and retain a minimum of 30 patients with Type 2 diabetes and obesity to participate in the program as well as 30 additional "control" patients who will receive routine care, and b) assess patient outcomes including weight loss and rates of diabetes remission using average blood sugar (hemoglobin A1c) over a six-month period. The healthy eating and active living to reverse diabetes (HEAL Diabetes) is a pilot study that aims to evaluate the feasibility, effectiveness, and operational and financial sustainability of a multicomponent health coach-supported nutrition intervention in a predominately African American population in Memphis, Tennessee. The investigators aim to assess study feasibility by evaluating recruitment, sample characteristics, intervention acceptability and procedural suitability. The investigators also aim to quantify and compare the treatment and control groups on primary outcomes including changes in body weight, hemoglobin A1c (HbA1c), and proportion of patients who achieved diabetes remission (HbA1c25 \< 6.5%) from baseline to 12-months. Additionally, the investigators aim to assess changes in diabetes self-efficacy and self-care activities and examine cost effectiveness of the multicomponent intervention. Drawing on evidence from DiRECT, MODEL, and related studies, the investigators hypothesize that the intervention arm will achieve greater weight loss and higher diabetes remission than the control. Additionally, the investigators hypothesize that the program will be operationally and financially sustainable.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

December 2, 2025

Last Update Submit

December 18, 2025

Conditions

Keywords

multicomponentbehavioral changelifestyledietweight losspragmatichealthy eatinghealth coachingcommunity-based diabetes care

Outcome Measures

Primary Outcomes (3)

  • Change in Body Weight

    Change in body weight in pounds from baseline to 6 months

    From enrollment to the end of 6 months.

  • Change in Hemoglobin A1c (HbA1c)

    Change in HbA1c (%) from baseline to 6 months

    Baseline to 6 months

  • Proportion of Participants Achieving Diabetes Remission

    Proportion of participants achieving diabetes remission at 6 months, defined as HbA1c \< 6.5% without use of glucose-lowering medications for at least 2 months

    6 months

Secondary Outcomes (4)

  • Change in Random Blood Glucose

    Baseline to 6 months

  • Change in Diabetes Self-Efficacy Score

    Baseline to 6 months

  • Change in Diabetes Self-Care Activities Score

    Baseline to 6 months

  • Cost of Intervention Delivery

    6 months

Study Arms (2)

Enhanced Care

ACTIVE COMPARATOR

Participants in this arm received enhanced usual care only. Enhanced usual care consisted of standard diabetes education, health coaching, and routine clinical management provided by their existing healthcare providers. No additional study-delivered classes, coaching, or materials were provided. Participants completed study assessments on the same schedule as the intervention group.

Behavioral: Enhanced Usual Diabetes Care

Intensive Care (Multicomponent Intervention)

EXPERIMENTAL

Participants in this arm received a structured, multicomponent diabetes remission intervention promoting healthy eating and intensive weight loss in addition to usual care. The intervention included biweekly group sessions over the study period, covering nutrition and weight management; cooking classes; individual health coaching; 3-month diet replacement; and physician-supervised medication discontinuation. The program also included goal-setting, progress check-ins, and supportive accountability delivered by health coaches. Participants completed the same study assessments as the enhanced care arm.

Behavioral: Intensive Multicomponent Healthy Eating and Weight Loss Intervention

Interventions

An intensive multicomponent diet and weight-loss intervention designed to support diabetes remission. The program included biweekly group sessions focused on low-carbohydrate, moderate-fat nutrition strategies; portion and calorie guidance; behavior-change skills; goal-setting; and weight-tracking. Participants also completed biweekly individual health-coaching sessions that provided personalized dietary guidance, problem-solving support, and adherence monitoring. The intervention incorporated 12 weeks of weekly total diet replacement provided through home delivery of lower-carbohydrate, lean-protein food items to facilitate adherence to dietary goals. During the total diet replacement phase participants also received physician-supervised medication discontinuation. Physical activity recommendations and strategies for managing blood glucose were also covered. The intervention was delivered by health coaches and provided in addition to participants' usual clinical care.

Intensive Care (Multicomponent Intervention)

Participants received enhanced usual diabetes care. This included optional diabetes self-management education provided through routine clinic services, individualized health-coaching sessions provided at neighborhood health hub facilities focused on general diabetes management support. In addition, participants received four produce vouchers valued at $50 each to promote access to fresh fruits and vegetables. No additional study-delivered classes, dietary programming, or supplemental food items were provided.

Enhanced Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults 18 years or older
  • a type 2 diabetes (T2D) duration of 0-6 years (diagnosis based on one recorded HbA1c test)
  • HbA1c value ≥ 6.5 percent at the screening visit
  • BMI ≥ 25 kg/m2
  • access to a cell phone or smartphone with texting and voicemail capabilities

You may not qualify if:

  • current use of insulin or more than two hypoglycemic medications (either oral or injectable)
  • a recent routine HbA1c greater than or equal to 12%
  • weight loss of \>5 kg within the last six months
  • inability to understand consent procedures, understand and speak English
  • pregnancy or considering pregnancy
  • diagnosis or exhibited unstable psychiatric condition, dementia, neurological disorder, or history of severe head trauma or brain tumor, and cognitive impairment
  • perceived unwillingness or inability to participate
  • planned move from the region during the study
  • participation in another clinical research trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UTHSC Health Hub-Uptown

Memphis, Tennessee, 38105, United States

Location

UTHSC Health Hub-ShelbyCares

Memphis, Tennessee, 38109, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes MellitusOverweightObesityWeight Loss

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director, Tennessee Population Health Consortium

Study Record Dates

First Submitted

December 2, 2025

First Posted

January 5, 2026

Study Start

October 11, 2023

Primary Completion

August 2, 2025

Study Completion

August 2, 2025

Last Updated

January 5, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the dataset contains sensitive, identifiable health information, and sharing could compromise participant privacy. Data are intended for use only by the study team for the purposes outlined in the study protocol.

Locations